Skip to Content

Chill Brands Group PLC CHLL

Morningstar Rating
GBX 2.00 −0.15 (6.98%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CHLL is trading at a 56% discount.
Price
GBP 2.26
Fair Value
GBP 9.60
Uncertainty
Extreme
1-Star Price
GBP 29.93
5-Star Price
GBP 8.99
Economic Moat
Jzgq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CHLL is a good fit for your portfolio.

Trading Information

Previous Close Price
GBX 2.15
Day Range
GBX 2.002.25
52-Week Range
GBX 1.7014.00
Bid/Ask
GBX 0.00 / GBX 0.00
Market Cap
GBX 1.01 Bil
Volume/Avg
1.0 Mil / 2.3 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
46.35
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Chill Brands Group PLC is engaged in the development, production, and distribution of CBD and lifestyle products. The CBD business sells wellness products in the United States and the United Kingdom under two brands Zoetic and Chill ranges. The chill brand is a tobacco alternative selling smokables and chew pouches. It generates revenue from the sale of CBD products. Geographically, group’s revenue is generated in the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
5

Valuation

Metric
CHLL
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
46.35
Price/Cash Flow
Price/Earnings
CHLL

Financial Strength

Metric
CHLL
Quick Ratio
0.65
Current Ratio
0.82
Interest Coverage
−7.56
Quick Ratio
CHLL

Profitability

Metric
CHLL
Return on Assets (Normalized)
−63.03%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−60.73%
Return on Assets
CHLL
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AHptylghbkDdy$72.4 Bil
MKKGY
Merck KGaA ADRYchwvjtwYpmdgv$70.8 Bil
HLN
Haleon PLC ADRZzyqbflvzCfwvc$38.2 Bil
VTRS
Viatris IncZpgvkrlmStc$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRRvqgmtqwMgc$12.5 Bil
CTLT
Catalent IncWflptkftTnqccqt$10.1 Bil
PRGO
Perrigo Co PLCKvypyztqjYzjp$4.3 Bil
CURLF
Curaleaf Holdings IncTzrcwmdfSzw$3.7 Bil
PBH
Prestige Consumer Healthcare IncHrqtylhdMlzjl$3.5 Bil
GTBIF
Green Thumb Industries IncGcwfqdwgHrncr$2.9 Bil

Sponsor Center